Sajwani and Williams identify obstacles in roll-out, including in relation to inadequate training, policy restrictions and stigma, whilst calling for further research to better understand the specifics of implementation and barriers in LMIC
CSFD identifies clear progress in the inclusion of gender issues and perspective in the new EU Drugs Strategy and Action plan, but recognises further development is crucial and provides recommendations.
HRI inventories a host of barriers in access to harm reduction services, including stigma, gender-based and structural violence, criminalisation, incarceration and limited gender-responsive and gender-affirming services.
The Global Fund outlines guidance for applicants to plan for and scale up effective HIV and HCV programming for people who use drugs, particularly those who inject.
UNAIDS unpacks the impact that gender inequalities, inequalities faced by key populations, and inequalities between children and adults have had on the AIDS response.
UNODC reports historical high levels of coca cultivation and potential coca production and offers insights into this increase, including as related to conditions of poverty and limited market access opportunities in rural areas of cultivation.
In tandem with the Urban Survivors Union and the Network of Drug Researchers with Lived Experience, Drug Policy Alliance provides recommendations to empower research participant communities and ensure communities benefit from research.
The Global Commission on Drug Policy puts forward recommendations to support effective and humane drug policy reforms that enhance peace, health, security and development in Colombia.
The Robert Carr Fund documents progress in strengthening the capacity of the 60 unique civil society networks it supports, including those in the Harm Reduction Consortium led by IDPC.
